Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Launched by CAREVIVE SYSTEMS, INC. · Aug 2, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how patients with breast cancer, lung cancer, ovarian cancer, multiple myeloma, or acute myelogenous leukemia are managing their symptoms while receiving treatment. The goal is to collect real-world information through an electronic system that allows patients to report their symptoms from home. This information will help improve care for cancer patients and build a database for future studies.

To participate, you need to be at least 18 years old and have one of the specified cancers, no matter what stage you are in your treatment. You should also be comfortable completing online surveys using a phone, tablet, or computer, and be able to understand English. If you join, you'll be asked to regularly report your symptoms, which will help doctors understand how treatments are affecting patients in everyday life. This trial is currently recruiting, and it’s a great opportunity to contribute to cancer research while receiving care.

Gender

All

Eligibility criteria

• Inclusion Criteria:
• • All participants must be 18 years of age or older.
• • Subjects may be any stage and anywhere in the treatment continuum.
• • Subject participants must have a diagnosis of a breast, lung, AML,ovarian cancer or multiple myeloma.
• • Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
• • All participants must be able to understand English.
• Exclusion Criteria:
• • Any patient who cannot understand written or spoken English
• • Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer
• • Any patient on a treatment clinical trial
• • Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D)